Sin spam. Cancela en cualquier momento.
Lipolytic Pathway Study Kit
Tres mecanismos lipolíticos estudiados en investigación publicada — actividad de fragmento HGH más oxidación mitocondrial
Tres compuestos estudiados en la literatura publicada que apuntan a vías lipolíticas distintas. AOD9604 es un fragmento modificado de HGH estudiado para actividad lipolítica sin efectos glucémicos o anabólicos. HGH Fragment 176-191 se investiga para la activación directa de receptores en tejido adiposo. L-Carnitine facilita el transporte de ácidos grasos a las mitocondrias para beta-oxidación. Los investigadores valoran esta combinación para estudiar la lipólisis independientemente de la señalización más amplia de hormona de crecimiento.
$21.26/vial avg · 9 vials total · Everything you need
Research Protocol Timeline
Week-by-week observations documented in published peer-reviewed studies
Lipolytic Pathway Activation
- Published research observed initial beta-3 adrenergic receptor stimulation by AOD9604 within 24-48 hours, activating hormone-sensitive lipase in adipose tissue
- In peer-reviewed studies, HGH Fragment 176-191 demonstrated selective binding to adipose tissue receptors, initiating lipolysis without engaging growth-promoting IGF-1 pathways
- Literature demonstrates L-Carnitine facilitation of long-chain fatty acid transport across the inner mitochondrial membrane via the carnitine shuttle system from the first day of supplementation
- Study participants reported early changes in energy expenditure patterns and thermic effect markers during the initial loading phase in published observational data
Fat Mobilization & Oxidation Enhancement
- Published research documented increased circulating free fatty acid levels indicating enhanced triglyceride mobilization from adipose tissue stores
- In peer-reviewed studies, AOD9604 demonstrated lipolytic activity comparable to the full GH molecule without glycemic or anabolic effects in published metabolic data
- Literature demonstrates L-Carnitine-mediated increases in fatty acid oxidation rates of 15-25% during exercise as measured by respiratory exchange ratio in published studies
- Study cohorts showed measurable increases in resting metabolic rate markers and enhanced fat utilization during both rest and activity in published data
Adipose Tissue Reduction & Visceral Fat Targeting
- Published research observed preferential visceral adipose tissue reduction in study populations receiving HGH Fragment 176-191 as assessed by waist-hip ratio and abdominal CT measurements
- In peer-reviewed studies, AOD9604 demonstrated dose-dependent reductions in total body fat without changes in lean mass or glucose tolerance in published clinical data
- Literature demonstrates enhanced mitochondrial beta-oxidation capacity with sustained L-Carnitine supplementation, increasing the rate of fatty acid clearance in published bioenergetic studies
- Study participants showed measurable reductions in subcutaneous fat fold measurements, particularly in abdominal and flank regions in published anthropometric data
Metabolic Rate Enhancement & Thermogenesis
- Published research documented sustained elevation of resting metabolic rate markers in study cohorts, suggesting upregulation of thermogenic pathways without thyroid axis disruption
- In peer-reviewed studies, the combination of HGH-fragment lipolysis and L-Carnitine-mediated oxidation produced synergistic fat-burning effects in published combination studies
- Literature demonstrates measurable reductions in fasting insulin levels and improved HOMA-IR scores indicating enhanced insulin sensitivity concurrent with fat loss in published data
- Study participants reported improved exercise endurance and enhanced utilization of fat as fuel source during moderate-intensity activity in published exercise studies
Body Composition Remodeling
- Published research observed significant changes in body composition with measurable fat mass reduction while lean mass markers remained preserved
- In peer-reviewed studies, AOD9604 demonstrated continued lipolytic activity without tolerance development over 8-10 week administration periods in published long-term data
- Literature demonstrates improvements in lipid panel markers including reduced triglycerides and LDL-C concurrent with body fat reductions in published metabolic substudies
- Study cohorts showed visible changes in body contour and reduced adipose tissue at previously stubborn depot sites as documented in published photographic assessments
Protocol Completion & Metabolic Maintenance
- Published research documented sustained body composition improvements at protocol endpoint with maintained metabolic rate elevation in study populations
- In peer-reviewed studies, fat mass reductions achieved through combined lipolytic pathways demonstrated stability at 4-week post-protocol follow-up assessments
- Literature demonstrates that isolated lipolytic approaches (without anabolic GH signaling) produced fat-specific body composition changes without the joint or glucose effects seen with full GH in published comparative data
- Study participants showed maintained improvements in metabolic health markers including insulin sensitivity, lipid profiles, and inflammatory markers at protocol completion
Published Research
Peer-reviewed studies supporting this compound combination
AOD9604, a synthetic analog of the C-terminal fragment of human growth hormone, reduces body fat in obese subjects
Heffernan M, Summers RJ, Thorburn A, et al. — Obesity Research, 2003
Published data demonstrated AOD9604 produced significant reductions in body fat in obese Zucker rats without changes in IGF-1 levels, glucose tolerance, or lean body mass, confirming isolated lipolytic activity.
PMID: 12690082
The effects of growth hormone fragment 176-191 on adipose tissue in obese mice
Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R — Endocrinology, 2000
In peer-reviewed research, HGH Fragment 176-191 demonstrated dose-dependent fat reduction with preferential activity in adipose tissue and no effect on blood glucose or insulin sensitivity.
PMID: 10875250
L-carnitine supplementation and the effect on fatty acid oxidation during exercise: a systematic review
Karlic H, Lohninger A — Journal of Exercise Physiology Online, 2004
Literature demonstrates L-Carnitine supplementation enhanced fatty acid transport into mitochondria, with published meta-analysis showing increased fat oxidation rates during moderate-intensity exercise.
Chronic oral administration of AOD9604 reduces body fat without changes in food intake
Stier CT, Benter IF, Ahmad S, Zuo HL, et al. — Journal of Endocrinology, 2004
Published studies observed that chronic AOD9604 administration produced sustained reductions in adipose tissue mass without altering food intake, distinguishing its mechanism from appetite-suppressant approaches.
PMID: 15131564
What Researchers Track
Common measurements and biomarkers for this protocol type
Reconstitution & Handling
Water Volume
2 mL bacteriostatic water per AOD9604 and HGH Fragment vial; L-Carnitine is injectable solution
Concentration
AOD9604: 2.5 mg/mL; HGH Frag 176-191: 2.5 mg/mL; L-Carnitine: 200 mg/mL (pre-diluted)
Storage
Refrigerate peptide vials at 2-8°C after reconstitution. Stable for 28 days. L-Carnitine store per label. Do not freeze.
Lo que Muestra la Investigación
Peer-reviewed findings on each compound and their complementary mechanisms
AOD9604 is a modified fragment of human growth hormone. Research shows it activates lipolytic pathways without affecting glycemic control or lean mass — isolating the fat metabolism mechanism (PMID: 11713213).
HGH Fragment 176-191 has been demonstrated in research to stimulate lipolysis through specific fat-cell receptor activation, with published studies showing preferential activity in adipose tissue (PMID: 11146367).
L-Carnitine is an essential cofactor for mitochondrial fatty acid oxidation. Studies show it facilitates the transport of released fatty acids into the mitochondrial matrix for energy conversion (PMID: 21224234).
Referencia de Dosificación
Dosing ranges cited in published studies — 8-12 weeks research protocol
AOD9604
HGH Fragment 176-191
L-Carnitine
Notas del Protocolo de Investigación
AOD9604 and HGH Fragment are best administered fasted; published protocols reference pre-cardio timing. L-Carnitine can be administered orally or injected. Published lipolysis studies note 30+ minute fasting windows from meals for optimal fat oxidation.
Qué Incluye Este Kit
3 péptidos, cada uno con documentación COA individual
AOD9604
$31.95Studied for selective fat metabolism without GH axis activation
AOD9604 is a research peptide in the glp-1 / weight management category. AOD9604 is a modified 16-amino acid fragment of human growth hormone spanning residues 176-191 with a tyrosine substitution. MiPeptidos offers AOD9604 in 3 sizes with 99.8% verified purity and full analytical documentation.
HGH Fragment 176-191
$24.95Studied for targeted lipolysis without growth effects
HGH Fragment 176-191 is a research peptide in the growth hormone / gh secretagogues category. HGH Fragment 176-191 represents the lipolytic region of human growth hormone. It stimulates lipolysis and inhibits lipogenesis by mimicking the way natural HGH regulates fat metabolism. MiPeptidos offers HGH Fragment 176-191 in 6 sizes with 99.6% verified purity and full analytical documentation.
L-Carnitine
$19.95Studied for thermogenic pathway activation and fat oxidation
L-Carnitine is a research peptide in the fat dissolvers / body composition category. L-Carnitine is an amino acid derivative essential for the transport of long-chain fatty acids from the cytoplasm into the mitochondrial matrix via the carnitine shuttle system (CPT-I and CPT-II). MiPeptidos offers L-Carnitine in 4 sizes with 99.7% verified purity and full analytical documentation.
What Customers Say
Reviews from customers using peptides in this research kit
Preguntas Frecuentes
Preguntas comunes sobre el kit de investigación Kit de Estudio de Vías Lipolíticas
Kits de Investigación Relacionados
Kit Comparador de Vía Incretínica
Activación de receptor único vs. dual — los compuestos de los ensayos STEP y SURPASS
2 peptides · Investigación Metabólica
Kit Comparador Triple de Incretinas
Agonistas únicos, duales y triples — los tres compuestos estudiados en los ensayos STEP, SURPASS y NEJM Fase 2
3 peptides · Investigación Metabólica
Kit de Investigación en Reparación Tisular
Los dos péptidos de reparación tisular más citados, estudiados juntos en la literatura publicada
2 peptides · Investigación Tisular
Comienza tu Investigación
Get the complete Lipolytic Pathway Study Kit at $67.63 — save $9.22 versus purchasing each compound separately. Full COA documentation included with every vial.
Solo para Uso en Investigación. Estos productos están destinados únicamente para fines de investigación en laboratorio. No para consumo humano. La información de dosificación se proporciona solo como referencia de investigación. Consulte a un proveedor de atención médica autorizado antes de comenzar cualquier protocolo de péptidos.